Genovis AB (publ.) (STO:GENO)
Sweden · Delayed Price · Currency is SEK 16.36
+0.16 (0.99%)
Mar 23, 2026, 2:48 PM CET
Genovis AB (publ.) Market Cap
Genovis AB (publ.) has a market cap or net worth of 1.07 billion as of March 23, 2026. Its market cap has decreased by -35.89% in one year.
Market Cap
1.07B
Enterprise Value
980.11M
Revenue
129.65M
Ranking
n/a
PE Ratio
45.35
Stock Price
16.36
Market Cap Chart
Since April 18, 2008, Genovis AB (publ.)'s market cap has increased from 7.51M to 1.07B, an increase of 14,143.87%. That is a compound annual growth rate of 31.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 1.07B | -23.76% |
| Dec 30, 2025 | 1.40B | -13.18% |
| Dec 30, 2024 | 1.62B | -52.50% |
| Dec 29, 2023 | 3.40B | 13.17% |
| Dec 30, 2022 | 3.01B | -37.05% |
| Dec 30, 2021 | 4.78B | 131.75% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Saniona AB | 2.08B |
| Egetis Therapeutics AB | 1.97B |
| Diamyd Medical AB | 1.87B |
| BioInvent International AB | 1.43B |
| Medivir AB | 1.16B |
| Xspray Pharma AB | 1.11B |
| Cantargia AB | 959.64M |
| SynAct Pharma AB | 945.31M |